{"entity":{"type":"insider","cik":"0001682068","url":"/insider/0001682068","json_url":"/insider/0001682068.json","name":"Regnante Keith","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":7,"first":"2018-02-21","last":"2026-02-20","span_basis":"filed_date"},"name_variants":[{"name":"Regnante Keith","source":"filing","n_filings":7,"first_seen":"2018-02-21","last_seen":"2026-02-20"}],"transactions":[{"id":5948918,"accession":"0001682068-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001682068-26-000003","line_url":"/filing/0001682068-26-000003#line-1","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001682068","owner_name":"Regnante Keith","owner_display_name":"Regnante Keith","owner_url":"/insider/0001682068","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4739.0,"shares_display":"4,739","price_per_share":16.35,"price_display":"16.35","price_state":"stated","total_value":77482.65,"total_display":"77,482.65","total_whole":"77,483","shares_owned_after":39261.0,"shares_owned_after_display":"39,261","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-20","scope":"insider"},{"id":9287317,"accession":"0001415889-25-002024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-002024","line_url":"/filing/0001415889-25-002024#line-1","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001682068","owner_name":"Regnante Keith","owner_display_name":"Regnante Keith","owner_url":"/insider/0001682068","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":45.29,"price_display":"45.29","price_state":"stated","total_value":1811600.0,"total_display":"1,811,600.00","total_whole":"1,811,600","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2025-01-24","scope":"insider"},{"id":2506069,"accession":"0001209191-24-001155","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-001155","line_url":"/filing/0001209191-24-001155#line-2","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001682068","owner_name":"Regnante Keith","owner_display_name":"Regnante Keith","owner_url":"/insider/0001682068","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":45.29,"price_display":"45.29","price_state":"stated","total_value":1811600.0,"total_display":"1,811,600.00","total_whole":"1,811,600","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-04","filed_date":"2024-01-08","scope":"insider"},{"id":8703491,"accession":"0001209191-23-036261","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-23-036261","line_url":"/filing/0001209191-23-036261","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001682068","owner_name":"Regnante Keith","owner_display_name":"Regnante Keith","owner_url":"/insider/0001682068","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":45.418371,"price_display":"45.42","price_state":"stated","total_value":908367.42,"total_display":"908,367.42","total_whole":"908,367","shares_owned_after":4007.0,"shares_owned_after_display":"4,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-09","filed_date":"2023-06-12","scope":"insider","n_lines":3},{"id":8703480,"accession":"0001209191-23-036261","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-036261","line_url":"/filing/0001209191-23-036261","is_derivative":false,"issuer_cik":"0001664710","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001664710","owner_cik":"0001682068","owner_name":"Regnante Keith","owner_display_name":"Regnante Keith","owner_url":"/insider/0001682068","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":47.7936005,"price_display":"47.79","price_state":"stated","total_value":955872.01,"total_display":"955,872.01","total_whole":"955,872","shares_owned_after":2699.0,"shares_owned_after_display":"2,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-12","scope":"insider","n_lines":2},{"id":7804487,"accession":"0000899243-19-004467","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-004467","line_url":"/filing/0000899243-19-004467#line-1","is_derivative":false,"issuer_cik":"0001631574","issuer_name":"Wave Life Sciences Ltd.","issuer_ticker":"WVE","issuer_name_source":null,"issuer_url":"/issuer/0001631574","owner_cik":"0001682068","owner_name":"Regnante Keith","owner_display_name":"Regnante Keith","owner_url":"/insider/0001682068","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1298.0,"shares_display":"1,298","price_per_share":36.8396,"price_display":"36.84","price_state":"stated","total_value":47817.8008,"total_display":"47,817.80","total_whole":"47,818","shares_owned_after":15686.0,"shares_owned_after_display":"15,686","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-19","filed_date":"2019-02-21","scope":"insider"},{"id":6812543,"accession":"0000899243-18-025320","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-025320","line_url":"/filing/0000899243-18-025320#line-2","is_derivative":false,"issuer_cik":"0001631574","issuer_name":"Wave Life Sciences Ltd.","issuer_ticker":"WVE","issuer_name_source":null,"issuer_url":"/issuer/0001631574","owner_cik":"0001682068","owner_name":"Regnante Keith","owner_display_name":"Regnante Keith","owner_url":"/insider/0001682068","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29500.0,"shares_display":"29,500","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":1622500.0,"total_display":"1,622,500.00","total_whole":"1,622,500","shares_owned_after":16984.0,"shares_owned_after_display":"16,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-24","filed_date":"2018-09-26","scope":"insider"},{"id":6811644,"accession":"0000899243-18-004949","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-004949","line_url":"/filing/0000899243-18-004949#line-1","is_derivative":false,"issuer_cik":"0001631574","issuer_name":"Wave Life Sciences Ltd.","issuer_ticker":"WVE","issuer_name_source":null,"issuer_url":"/issuer/0001631574","owner_cik":"0001682068","owner_name":"Regnante Keith","owner_display_name":"Regnante Keith","owner_url":"/insider/0001682068","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":316.0,"shares_display":"316","price_per_share":51.85,"price_display":"51.85","price_state":"stated","total_value":16384.6,"total_display":"16,384.60","total_whole":"16,385","shares_owned_after":16984.0,"shares_owned_after_display":"16,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-16","filed_date":"2018-02-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001664710","name":"Keros Therapeutics, Inc.","url":"/issuer/0001664710","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":4,"first_seen":"2023-06-12","last_seen":"2026-02-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001631574","name":"Wave Life Sciences Ltd.","url":"/issuer/0001631574","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2018-02-21","last_seen":"2019-02-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001682068","retrieved_at":"2026-08-24T20:14:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}